Industry Educational Session - Exploring Genomic Signatures in Malignant Lymphoma: Advantages for Early Detection, Treatment, and Monitoring under Research Use Only (RUO) Guidelines - Sponsored by Thermofisher Scientific
Tracks
Track 4
| Tuesday, April 30, 2024 |
| 12:20 PM - 1:05 PM |
| Room 11C |
Details
At Thermo Fisher Scientific, we are powering the future of molecular testing and clinical trial. In this symposium, we will focus on our recent advanced NGS solution” Ion AmpliSeq Liverpool Lymphoid Network Panel” which designed to profile key DNA mutations relevant for T-cell and B-cell lymphomas, leukemias and lymphoproliferative neoplasms
